Total planned funding: $92,873,220
Allocations
Countries/Regions
Ukraine | $92,873,220 |
Organizational Types
Private Contractor | $27,778,578 |
Unknown | $22,843,032 |
NGO | $11,221,998 |
Multi-lateral Agency | $10,138,586 |
Own Agency | $9,751,932 |
Other USG Agency | $4,589,094 |
University | $3,850,000 |
Implementing Agency | $2,700,000 |
Program Areas
Governance and Systems | $38,572,368 |
Treatment | $22,102,678 |
Prevention | $9,676,253 |
Testing | $9,277,529 |
Care | $6,902,282 |
Management and Operations | $6,342,110 |
Budget Codes
OHSS: Health Systems Strengthening | $19,035,503 |
HTXD: Treatment: ARV Drugs | $11,405,290 |
HVSI: Strategic Information | $11,241,601 |
HTXS: Treatment: Adult Treatment | $10,697,388 |
HVCT: Testing: HIV Testing and Counseling | $9,277,529 |
HLAB: Laboratory Infrastructure | $8,295,264 |
HVMS: Management and Operations | $6,342,110 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,647,216 |
HVTB: Care: TB/HIV | $3,706,813 |
HVOP: Sexual Prevention: Other Sexual Prevention | $2,660,348 |
HMBL: Biomedical Prevention: Blood Safety | $1,942,932 |
HKID: Care: Orphans and Vulnerable Children | $1,609,128 |
HBHC: Care: Adult Care and Support | $1,586,341 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $132,400 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$22,843,032
Countries/Regions
Chemonics International:
$16,839,470
Countries/Regions
Deloitte Consulting Limited:
$10,239,108
Countries/Regions
USG Aggregated Agencies:
$8,936,932
Countries/Regions